CN Patent
CN101772494B — 4-嘧啶磺酰胺衍生物
Assigned to Aidu West Pharmaceutical Co Ltd · Expires 2013-05-15 · 13y expired
What this patent protects
本发明关于一种结构式I的化合物及其盐 该化合物作为内皮素受体拮抗剂。本发明进一步关于一种制备该化合物的方法。
USPTO Abstract
本发明关于一种结构式I的化合物及其盐 该化合物作为内皮素受体拮抗剂。本发明进一步关于一种制备该化合物的方法。
Drugs covered by this patent
- Tryvio (APROCITENTAN) · Idorsia
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.